Rozanolixizumab (Anti-FcRn (FCGRT & B2M))

Ask supplier a question | View on supplier's website

Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) is a high-affinity humanized monoclonal antibody, targeting human neonatal Fc receptor (FcRn) and is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases. MW: 150 KD.

Supplier	Selleck Chemicals
Product #	A2500
Sku #	A2500-1mg
Pricing	1mg, $370.00

Feedback